insights_auto
Why is ORX up 5,76%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,90 SEK
arrow_upward
+5,76%(+0,049) 1D
17 қар., 17:29:55 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
315,79 млн
Avg. vol.
790,03 м.
Volume
719,07 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
315,79 млн
Avg. vol.
790,03 м.
Volume
719,07 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 сағат бұрын
S&P 500 After-Hours Gainers for Nov. 17, 2026
BigGo Finance
·
48 минут бұрын
New York Stocks Slip a Day Before Nvidia Earnings; S&P 500, Nasdaq Fall for Fourth Straight Session
BigGo Finance
·
1 сағат бұрын
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
Traders Union
·
2 сағат бұрын
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com